跳至主要内容
临床试验/NCT07655596
NCT07655596尚未招募4 期

Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During Orthopedic Surgeries in Egyptian Patients.

Helwan University0 个研究点目标入组 100 人开始时间: 2026年7月1日最近更新:
干预措施

试验速览

阶段
4 期
状态
尚未招募
入组人数
100

研究概览

简要总结

A randomized controlled trial on adults who underwent orthopedic surgery. To evaluate the effectiveness of intraoperative continuous infusion (CI) of cefazolin compared with intermittent (INT) cefazolin administration in preventing SSIs in the orthopedic surgical population.

Eligible patients will be randomized in a block design into 2 groups: intervention and control. The intervention group will use continuous infusion of cefazolin (CI), while the control group will follow the traditional presurgical prophylaxis protocol of intermittent cefazolin doses (INT).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Orthopaedic surgical ward patients who underwent major surgery.

排除标准

  • Patients who require reoperation within 30 days.
  • Immunosuppressant patients.
  • Patients who are not adherent to the protocol time or dosing, either preoperatively, during, or postoperatively.
  • Pregnancy or breastfeeding.

研究组 & 干预措施

Continuous infusion of cefazolin

Experimental

干预措施: Cefazolin 2 g Infusion (Drug)

Intermittent cefazolin injection

Active Comparator

干预措施: Cefazolin 2 GM Injection (Drug)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hebatallah Ali Abdeen

Principal Investigator

Helwan University

相似试验